July 25, 2020
What is MDS? How Do We Determine Prognosis?
What is MDS? How Do We Determine Prognosis?
This webinar will provide an overview of MDS and how prognosis is determined, focusing on the MDS subtypes and disease process of MDS. Understanding the diagnosis of MDS, details about the various approaches to treatment, and answers to common questions will be discussed.
Speaker
JS
Jamile Shammo, MD
Outputs
Access to the meeting outputs are available below by clicking on each topic.
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, and Acceleron for supporting this initiative.
